Humacyte Inc

HUMANASDAQ · USD
0.59USD+0.01 (+1.91%)
122

Humacyte Inc (HUMA) Options Open Interest

HUMA options open interest is 102,211 contracts. The 2-week average daily volume is 743 contracts across the chain.

Read more

Monitoring HUMA open interest helps you see where real money is positioned on Humacyte Inc's options and which strikes are attracting the most commitment from traders. Humacyte Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor HUMA options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising HUMA options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Humacyte Inc to settle.

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; and coronary artery bypass grafting, as well as developing its HAVs for pediatric heart surgery and cellular therapy delivery, including pancreatic islet cell transplantation to treat Type 1 diabetes.

The company was founded in 2004 and is headquartered in Durham, North Carolina.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where HUMA open interest is concentrated. Our scanner maps Humacyte Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Humacyte Inc's options open interest as the signal it is, not as an afterthought.

2026-09-18
Calls
1.000.050.051,000%+0.14591,841
2.500.050.051,000%+0.00071,345
1.500.050.051,000%+0.02281,069
2.000.050.051,000%+0.00381,024
0.500.150.151,000%+0.7125256
Puts
1.000.350.450.4089%-1.0000705
0.500.050.05916%-0.2829313
1.500.553.502.031,000%-0.97729
2.001.054.002.531,000%-0.99623
2.501.552.502.031,000%-0.99930

As of September 17, 2026

Follow the money

Track HUMA open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial